189 related articles for article (PubMed ID: 6302462)
1. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
Sizemore GW; Hpeath H; Larson JM
J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
[TBL] [Abstract][Full Text] [Related]
5. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
[TBL] [Abstract][Full Text] [Related]
6. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
Birnbaum RS; Muszynski M; Roos BA
Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
[TBL] [Abstract][Full Text] [Related]
7. A new bioactive form of human calcitonin.
Tobler PH; Dambacher MA; Born W; Heitz PU; Maier R; Fischer JA
Cancer Res; 1983 Aug; 43(8):3793-9. PubMed ID: 6861143
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
11. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
12. Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma.
Conlon JM; McGregor GP; Wallin G; Grimelius L; Thim L
Cancer Res; 1988 May; 48(9):2412-6. PubMed ID: 3258543
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma.
Shibasaki T; Deftos L; Guillemin R
Biochem Biophys Res Commun; 1979 Oct; 90(4):1266-73. PubMed ID: 229834
[No Abstract] [Full Text] [Related]
14. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique.
Butler M; Khan S
Arch Pathol Lab Med; 1986 Jul; 110(7):647-9. PubMed ID: 2424399
[TBL] [Abstract][Full Text] [Related]
16. Localization of a radiolabeled monoclonal antibody to calcitonin in rat medullary thyroid carcinoma allografts.
Samaan NA; Yang KP
Henry Ford Hosp Med J; 1987; 35(2-3):153-6. PubMed ID: 3692888
[No Abstract] [Full Text] [Related]
17. [Human calcitonin in plasma and tissues. II. Calcitonin in tumor tissues (author's transl)].
Adachi I
Nihon Naika Gakkai Zasshi; 1977 Jun; 66(6):648-54. PubMed ID: 199678
[No Abstract] [Full Text] [Related]
18. A carbohydrate-containing form of immunoreactive calcitonin in transplantable rat medullary thyroid carcinomas.
O'Neil JA; Birnbaum RS; Jacobson A; Roos BA
Endocrinology; 1981 Mar; 108(3):1098-100. PubMed ID: 7460837
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical heterogeneity of calcitonin in plasma.
Deftos LJ; Roos BA; Bronzert D; Parthemore JG
J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
[TBL] [Abstract][Full Text] [Related]
20. [Calcitonin levels in tissue culture of thyroid medullary carcinoma].
Martin RC; Ezabella MC; Toledo SP
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(5):220-2. PubMed ID: 3836475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
